Renin-Angiotensin Blockade After Aortic Valve Replacement

In a retrospective, observational analysis, RAS blockade was associated with reduced mortality.

Many patients with severe aortic stenosis have ventricular hypertrophy and diastolic dysfunction. The use of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin-receptor blockers (ARBs) is associated with improvements in left ventricular remodeling and hypertrophy in patients with heart failure. To ascertain the effect of renin–angiotensin system (RAS) blockade on outcomes after surgical aortic valve replacement (SAVR) for severe aortic stenosis, investigators from the Cleveland Clinic conducted a retrospective, observational study of 741 patients who received RAS blockade after SAVR and 1011 SAVR patients who did not.

Mean age was similar in both groups. The RAS blockade group included 598 patients (80.7%) treated with an ACEI (m…

Reviewing Author

Joel M. Gore, MD

Disclosures

Grant/Research SupportNIH–National Heart, Lung, and Blood Institute

Joel M. Gore, MD

Disclosures

Grant/Research SupportNIH–National Heart, Lung, and Blood Institute

Renin-Angiotensin Blockade After Aortic Valve Replacement

Topics

Reviewing Author